Chiron Response To FDA "483" Report For Fluvirin Plant Expected In Early August
FDA issued its observations following a nine-day inspection of the company's Liverpool, U.K. manufacturing facility in mid-July.
FDA issued its observations following a nine-day inspection of the company's Liverpool, U.K. manufacturing facility in mid-July.